Clark Estates Inc’s Meridian Bioscience Inc VIVO Stock Holding History

Clark Estates Inc’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-220,000	Closed	-$4.49M	–	108
2021 Q4	$4.49M	Hold	220,000	–	–	0.66%	49
2021 Q3	$4.23M	Hold	220,000	–	–	0.6%	50
2021 Q2	$4.88M	Hold	220,000	–	–	0.64%	43
2021 Q1	$5.78M	Hold	220,000	–	–	0.74%	35
2020 Q4	$4.11M	Hold	220,000	–	–	0.58%	46
2020 Q3	$3.74M	Buy	+220,000	New	+$4.28M	0.61%	40
2018 Q1	–	Sell	-227,000	Closed	-$3.18M	–	99
2017 Q4	$3.18M	Hold	227,000	–	–	0.52%	63
2017 Q3	$3.25M	Hold	227,000	–	–	0.54%	58
2017 Q2	$3.58M	Hold	227,000	–	–	0.61%	29
2017 Q1	$3.13M	Buy	+227,000	New	+$3.17M	0.48%	51

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VLKIM

Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clark Estates Inc's VIVO Position: Q1 2022 in Review

Clark Estates Inc sold out of Meridian Bioscience Inc (VIVO) in Q1 2022, closing a stake of 220,000 shares — an estimated $4.49M sold.

Clark Estates Inc first reported a position in VIVO in Q1 2017 and held it in 10 quarters. The position peaked at $5.78M in Q1 2021. 210 funds tracked by Wall St. Rank hold VIVO as of Q1 2022.

Clark Estates Inc reported no remaining Meridian Bioscience Inc position as of Q1 2022 after selling out during the quarter.
Clark Estates Inc sold 220,000 Meridian Bioscience Inc shares in Q1 2022, an estimated $4.49M.
Clark Estates Inc first reported a position in Meridian Bioscience Inc in Q1 2017 and held it in 10 quarters.
Clark Estates Inc's Meridian Bioscience Inc position peaked at $5.78M in Q1 2021.
210 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2022.

Based on Clark Estates Inc's 13F filing for Q1 2022, filed 13 May 2022.